Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amoxicillin trihydrate,potassium clavulanate -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amoxicillin trihydrate,potassium clavulanate -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - potassium clavulanate, quantity: 13.58 mg/ml (equivalent: clavulanic acid, qty 11.4 mg/ml); amoxicillin trihydrate, quantity: 91.84 mg/ml (equivalent: amoxicillin, qty 80 mg/ml) - suspension, powder for - excipient ingredients: citric acid; guar gum; sodium citrate; purified talc; aspartame; silicon dioxide; flavour - short-term treatment of the following bacterial infections when caused by sensitive organisms: skin and skin structure infections; urinary tract infections (complicated and uncomplicated); upper respiratory tract infections including sinusitis and otitis media; lower respiratory tract infections including acute exacerbations of chronic bronchitis and community acquired pneumonia. appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to curam duo 400/57. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in microbiology, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to curam duo 400/57 should not require the addition of another antibiotic due to the amoxycillin content of curam duo 400/57.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 573.394 mg (equivalent: amoxicillin, qty 500 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate; patent blue v; carmoisine - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms:,note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results.,skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli. (see microbiology),respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli. (see microbiology),genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbioology), p.mirabilis and s.faecalis.,gonorrhoea: n.gonorrhoeae (non-penicillinase producing).,prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 286.697 mg (equivalent: amoxicillin, qty 250 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate; patent blue v; carmoisine - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms:,note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results.,skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli. (see microbiology),respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli. (see microbiology),genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbioology), p.mirabilis and s.faecalis.,gonorrhoea: n.gonorrhoeae (non-penicillinase producing).,prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kela sa-nv - amoxicillin trihydrate 817,7 mg - eq. amoxicillin 700 mg/g - powder for use in drinking water/milk - 700 mg/g - amoxicillin trihydrate - amoxicillin - poultry; pig; cattle

Kanada - angleščina - Health Canada

sivem pharmaceuticals ulc - amoxicillin (amoxicillin trihydrate) - capsule - 250mg - amoxicillin (amoxicillin trihydrate) 250mg - aminopenicillins

Kanada - angleščina - Health Canada

sivem pharmaceuticals ulc - amoxicillin (amoxicillin trihydrate) - capsule - 500mg - amoxicillin (amoxicillin trihydrate) 500mg - aminopenicillins

Kanada - angleščina - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - capsule - 250mg - amoxicillin (amoxicillin trihydrate) 250mg - aminopenicillins

Kanada - angleščina - Health Canada

pharmascience inc - amoxicillin (amoxicillin trihydrate) - capsule - 500mg - amoxicillin (amoxicillin trihydrate) 500mg - aminopenicillins